From Foundational Discovery
to Translational Success
Driving Oncology Innovation Across the Full Drug Development Continuum
Oncology Research
Solutions
Basic Oncology Research
We deliver comprehensive foundational oncology research services to support early-stage target identification and biological hypothesis validation. Leveraging disease-relevant models, functional assays, and biomarker analyses, we generate high-quality, actionable data that inform strategic decisions throughout drug discovery and development.
Access Immuno-Oncology Services
Small-Molecule Drug Discovery
Our small-molecule discovery capabilities span hit identification, lead optimization, and mechanism-based profiling. By integrating medicinal chemistry, in vitro and in vivo pharmacology, and translational insights, we accelerate the development of candidates with enhanced efficacy, safety, and developability.
Advance Ferroptosis Drug Discovery
Biologic Therapeutics Development
We provide end-to-end support for biologic therapeutics across the drug development continuum—from early discovery to IND-enabling and preclinical studies. Our phase-aligned approach ensures scientific rigor, scalability, and regulatory compliance at each development milestone.
Accelerate Antibody & Protein Development
Therapeutic Modality Portfolio
Our portfolio spans diverse therapeutic modalities, including small molecules, monoclonal antibodies, cell therapies, and emerging platforms. This multi-modality expertise allows us to design and execute tailored strategies that address complex oncology targets and unmet clinical needs.
Compare Immunotherapy Modalities
MOA–Driven Solutions
We deliver mechanism-of-action–driven strategies that align experimental design with biological pathways and disease mechanisms. Anchoring discovery and development efforts to defined MOAs enhances predictive pharmacology, translational relevance, and informed go/no-go decision-making.
Uncover Cancer Resistance Mechanisms
Translational Oncology Research Support
Our translational oncology services bridge preclinical research and clinical development. Through biomarker strategies, pharmacodynamic assessment, and clinically relevant models, we convert scientific insights into actionable data that support clinical readiness and maximize development success.
Total Immunology Solutions at Creative Biolabs
We provide fully integrated solutions that combine our products and services, supporting clients across the entire pharmaceutical development process—from discovery to clinical translation.
Our approach ensures seamless workflows, enhanced efficiency, and reliable outcomes at every stage of drug development.
Custom Assay Kit
- Oncology Kit
- Tumor Marker Kit
- Cell Transplantation Kit
Custom Engineered Cell Line
- Oncology Cell Line
- Oncolmmune Cells
- Synthetic Gene Circuit Cell
Creative Biolabs: Quality You Can Trust
Basic QC
Functional QC
PharmaOnco™ Mouse 4T1-Luc-GFP Reporter Tumor Cell Line
PharmaOnco™ Molm13-nLuc-GFP Reporter Cell Line
PharmaOnco™ Human SKOV3 Luc Reporter Tumor Cell Line
Targeting the Hallmarks of Cancer Through Immunology
The Next Chapter in Immunotherapy, Today
Advance Targeted Therapy with Tumor Profiling
Discover Our Products by Brand
Open for collaborations across discovery, development, and manufacturing.
Our passion comes from focusing on the new chapter in cancer treatment, and we believe that next-generation immunotherapy will provide us with the best opportunity to discover and advance the drug pipeline for our global partners.
Join Us
